{"brief_title": "Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.", "brief_summary": "To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.", "condition": "Breast Neoplasms", "intervention_type": "Drug", "intervention_name": "tamoxifen", "criteria": "Inclusion Criteria 1. Locally advanced or metastatic breast cancer 2. Bi-dimensionally measurable disease Exclusion Criteria 1. Prior hormonal therapy", "gender": "Female", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00034125.xml"}